P.2.f.028 Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site, randomised controlled trial
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Still being checked.
Cited by
Sorted by citations
Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model
Price, R. B., & Duman, R. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0615-x · Cited by 721 · see citing works
Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial
Taylor, J. H., Landeros-Weisenberger, A., Coughlin, C., Mulqueen, J., Johnson, J. A., Gabriel, D., Reed, M. O., Jakubovski, E., & Bloch, M. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.194 · Cited by 142 · see citing works
Effect of ketamine combined with DHA on lipopolysaccharide-induced depression-like behavior in rats
Chang, D., Zhao, J., Zhang, X., Lian, H., Du, X., Yuan, R., Wen, Y., & Gao, L. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105788 · Cited by 33 · see citing works
Effectiveness and Safety of Ketamine for Unipolar Depression: a Systematic Review
Memon, R. I., Naveed, S., Faquih, A. E., Fida, A., Abbas, N., Chaudhary, A. M. D., & Qayyum, Z. (2020) · Psychiatric Quarterly · doi:10.1007/s11126-020-09830-6 · Cited by 20 · see citing works
Ketamine and chronic treatment-resistant depression: real-world practice and after relapse
Jobnah, S., Latifeh, Y., Kabani, D. A., & Youssef, L. A. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06203-2 · Cited by 8 · see citing works
Ketamine Infusions: Role and Use in Ambulatory Surgery Centers
Kikkeri, S., Mosel, L., Patil, S. S., Siddaiah, H. B., & Shah, R. V. (2021) · Springer eBooks · doi:10.1007/978-3-030-55262-6_15 · Cited by 2 · see citing works
- Authors
- Murrough, J. W., Iosifescu, D. V., Chang, L., Al Jurdi, R. K., Green, C., Perez, A., Iqbal, S. Z., Pillemer, S., Foulkes, A., & Mathew, S.
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 23
- Pages
- S411-S412
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2329893288
- Cited by
- 4
- References
- 0
- Citations by year
- 2024: 1 · 2021: 1 · 2020: 1 · 2019: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Neuropsychopharmacology (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- ketamine, treatment-resistant depression, major depressive disorder, antidepressant efficacy, sertraline, adjuvant therapy, oral ketamine, adverse effects
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
